Emoxypine

Emoxypine
Clinical data
Trade names	Mexidol
Other names	Emoxipine, Emoxypin, Epigid, 6-Methyl-2-ethyl-3-hydroxypyridine
Routes of; administration	Oral & IV
ATC code	none;
Legal status
Legal status	US: Unscheduled; not FDA approved; RU: Rx only;
Pharmacokinetic data
Elimination half-life	2-2.6 h
Identifiers
	IUPAC name 2-Ethyl-6-methyl-3-hydroxypyridine;
CAS Number	2364-75-2;
PubChem CID	114681;
ChemSpider	102688 ;
UNII	V247P5H4E1;
CompTox Dashboard (EPA)	DTXSID40178313 ;
ECHA InfoCard	100.205.098
Chemical and physical data
Formula	C8H11NO
Molar mass	137.182 g·mol−1
3D model (JSmol)	Interactive image; Interactive image;
Melting point	170 to 172 °C (338 to 342 °F)
	SMILES CCc1c(ccc(n1)C)O; ; Oc1ccc(nc1CC)C;
	InChI InChI=1S/C8H11NO/c1-3-7-8(10)5-4-6(2)9-7/h4-5,10H,3H2,1-2H3; Key:JPGDYIGSCHWQCC-UHFFFAOYSA-N;
	(verify)

Emoxypine (2-ethyl-6-methyl-3-hydroxypyridine), also known as Mexidol or Mexifin, a succinate salt, is chemical compound which is claimed by its manufacturer, the Russian company Pharmasoft Pharmaceuticals, to have antioxidant and actoprotector properties, but these purported properties of emoxypine have not been proven. Its chemical structure resembles that of pyridoxine (a type of vitamin B₆).